首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Distribution and binding parameters of GABAA receptors in the thalamic nuclei of Macaca mulatta and changes caused by lesioning in the globus pallidus and reticular thalamic nucleus.
【24h】

Distribution and binding parameters of GABAA receptors in the thalamic nuclei of Macaca mulatta and changes caused by lesioning in the globus pallidus and reticular thalamic nucleus.

机译:猕猴丘脑核中GABA A受体的分布和结合参数以及苍白球和网状丘脑核的损伤引起的变化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ascending output from the basal ganglia to the primate motor thalamus is carried by GABAergic nigro- and pallido-thalamic pathways, which interact with intrinsic thalamic GABAergic systems represented in primates by local circuit neurons and axons of the reticular thalamic nucleus. Disease-triggered pathological processes in the basal ganglia can compromise any of these pathways either directly or indirectly, yet the effects of basal ganglia lesioning on its thalamic afferent-receiving territories has not been studied in primates. Two GABA(A) receptor ligands, [(3)H]muscimol and [(3)H]flunitrazepam, were used to study the distribution and binding properties of the receptor in intact monkeys, those with kainic acid lesions in the globus pallidus, and those with ibotenic acid lesions in the reticular nucleus using quantitative autoradiographic technique on cryostat sections of fresh frozen brain tissue. In control monkeys the binding affinities for [(3)H]muscimol averaged 50 nM in the thalamic nuclei and86 nM in the basal ganglia while the binding densities varied (maximum density of binding sites [Bmax] range of 99.4-1000.1 fmol/mg of tissue). Binding affinities and Bmax values for [(3)H]flunitrazepam averaged 2.02 nM and 81-113 fmol/mg of tissue, respectively. Addition of 100-microM GABA increased average affinity to 1.35 nM whereas Bmax values increased anywhere from 1-50% in different nuclei. Zolpidem (100 nM) decreased binding by 68-80%. Bmax values for both ligands were decreased at the two survival times in both medial and lateral globus pallidus implying involvement of both nuclei in the lesion. Statistically significant, 40% decrease (P=0.055) of Bmax for [(3)H]muscimol was observed in the ventral anterior nucleus pars densicellularis (VAdc, the main pallidal projection territory in the thalamus) 1 week after globus pallidus lesioning and a 36% decrease (P=0.017) 4 months post-lesioning. In contrast, [(3)H]flunitrazepam Bmax values in the VAdc of the same animals were increased by 23% (P=0.021) at 1week and 28% (P=0.005) 4 months postlesion, respectively. One week after the reticular nucleus lesioning, the binding densities of [(3)H]muscimol and [(3)H]flunitrazepam were decreased in the thalamic nuclei receiving projections from the lesioned reticular nucleus sector by approximately 50% (P<0.05) and 10-33% (P<0.05), respectively. The results suggest that different GABA(A) receptor subtypes are associated with different GABAergic systems in the thalamus which react differently to deafferentation.
机译:从基底神经节到灵长类运动丘脑的输出升高是由GABA能性黑质和巴利多-丘脑途径携带的,它们与固有的丘脑GABA能系统相互作用,在灵长类中由局部回路神经元和网状丘脑核的轴突相互作用。基底神经节中由疾病触发的病理过程可直接或间接破坏任何这些途径,但是尚未在灵长类动物中研究基底神经节病变对其丘脑传入接收区域的影响。使用两种GABA(A)受体配体[[(3)H]麝香酚和[(3)H]氟硝西m)来研究该受体在完整猴中的分布和结合特性,这些人在苍白球中有红藻酸损害,定量放射自显影技术对新鲜冰冻的脑组织的低温恒温器切片以及网状细胞核中具有ibotenic酸损伤的患者。在对照猴子中,[(3)H]麝香酚的结合亲和力在丘脑核中平均为50 nM,在基底神经节中平均为86 nM,而结合密度却有所不同(结合位点的最大密度[Bmax]范围为99.4-1000.1 fmol / mg组织)。 [(3)H]氟硝西m的结合亲和力和Bmax值分别平均为2.02 nM和81-113 fmol / mg组织。添加100-microM GABA可使平均亲和力增加至1.35 nM,而在不同核中,Bmax值会增加1-50%。唑吡坦(100 nM)使结合降低68-80%。在内侧和外侧苍白球的两个存活时间,两种配体的Bmax值均降低,这意味着病变中两个核都参与了。具有统计学意义的是,在苍白苍白球病变后1周,腹侧前核denscellularis(VAdc,丘脑的主要苍白球投射区域)的[(3)H]麝香酚的Bmax降低了40%(P = 0.055)。病变4个月后减少36%(P = 0.017)。相比之下,相同动物的VAdc中的[(3)H]氟硝西m Bmax值在病变后1周分别增加了23%(P = 0.021)和在患病后4个月增加了28%(P = 0.005)。网状核损伤后一周,丘脑核中[(3)H] muscimol和[(3)H]氟硝西m的结合密度降低,从受损的网状核扇区投射出约50%(P <0.05)和10-33%(P <0.05)。结果表明,不同的GABA(A)受体亚型与丘脑中不同的GABA能系统相关,后者对脱除咖啡因的反应不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号